It has been reported that E-cadherin engagement leads to ERK inhibition in a PI3K/Akt-dependent pathway in differentiating intestinal epithelial cells [27], and in KRAS-mutated colorectal cancers, suggesting PLCD1 may suppress phosphorylation of ERK by engaging E-cadherin [7]. Here, KRAS is linked to colorectal cancer.